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Abstract
To some extent, antibiotics are similar to addictive goods, since current
consumption is reinforced by past use because of bacterial resistance, which
represents a growing concern in many countries. The purpose of this paper
is to explore how consumers adjust their current level of antibiotic consump-
tion towards desired levels over time. We construct a balanced panel dataset
(2000-2007) for 20 Italian regions and estimate a dynamic model where an-
tibiotic consumption depends upon demographic and socioeconomic char-
acteristics of the population, the supply of health care in the community,
antibiotic price, and the capital stock of endogenous bacterial resistance
measured by past consumption. We apply alternative dynamic estimators
for short panels: the bias-corrected least squares dummy variable (LSDVC)
and the system Blundell-Bond GMM estimator (GMM-BB). The estimation
results are stable across di¤erent model specications and show that antibi-
otic use in previous periods has a positive impact on current antimicrobial
consumption (between 0.14 and 0.39). This indicates that the process of
adjustment to desired levels of consumption is relatively fast (approximately
1.2-1.6 years). Weak persistence in consumption may suggest that individuals
are responsive to changes in antibiotic e¤ectiveness.
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1 Introduction
The increasing use of antibiotics and the consequent harmful e¤ects of bacterial
resistance have become a growing concern in many countries. Evidence suggests
that bacterial resistance grows with antibiotic use and may regress when antibi-
otic consumption is controlled (Monroe and Polk, 2000; Mera et al., 2006). It has
been shown that the potential welfare loss due to bacterial resistance may account
for up to 12% of total outpatient antibiotic expenditure (Filippini et al., 2009a).
Although public interventions may be e¤ective in controlling antibiotic consump-
tion (Huttner et al., 2010), the e¤ects of intervention policies on resistance to
antimicrobial drugs cannot be assessed accurately at present. The consumption
dynamics of antibiotics and its behavioural aspects are still unclear.
To some extent, antibiotics are similar to addictive goods since individuals
may develop dependence or experience persistent attitudes towards consumption.
Addiction is a negative side-e¤ect of consumption where the characteristics of
goods interact with the characteristics of individuals. Consumption of addictive
goods is characterized by reinforcement (higher levels of consumption in the past
increases the desire for present consumption) and tolerance (utility of a given level
of consumption is lower when past consumption is higher) (Peper, 2004). In the
case of antibiotics, current consumption may be a¤ected by past consumption
because of endogenous bacterial resistance. Past consumption increases bacterial
resistance, i.e the capital stock, which in turn reduces the e¤ectiveness of an-
tibiotic use over time (Laxminarayan and Brown, 2001; Herrmann and Gaudet,
2009).
To our knowledge, the study of antibiotic consumption is limited to the inves-
tigation of cross-sectional data (Kern et al., 2006; Filippini et al., 2006). However,
as suggested above, dynamic aspects of consumption may play an important role
since the spread of antimicrobial resistance reduces antibiotic e¤ectiveness on each
individual as well as for other individuals in the community (external e¤ects) and
could be related to behavioural factors. From the empirical point of view, we
should note that data on the capital stock, i.e. the level of bacterial resistance,
are unfortunately not usually available.
Econometric models may incorporate the inuence of consumption habits on
preferences over time (Spinnewyn, 1981). To include habits or addiction aspects in
models of antibiotic consumption one can drop the assumption that an increase in
current consumption has just an impact on current individuals utility and assume
correlation between consumption and utility in subsequent periods. Indeed, this
is the case if antibiotics are an exhaustible resource since their e¢ cacy may be
reduced by endogenous bacterial resistance.
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Plausibly, individuals (and their doctors) are myopic in the sense that the
e¤ect of present antibiotic consumption on future consumption are not taken into
account in their consumption choices. Past consumption is supposed to a¤ect
present consumption only through the reduced level of antibiotic e¤ectiveness.
Past antibiotic consumption can either be taken into account by means of lagged
or stock variables included in empirical models of consumption. Lagged variables
have been considered, for instance, in Baltagi and Levin (1986), to estimate the
demand for cigarettes, and by Johnson and Oskanen (1977) to study the demand
for alcohol (Bretteville-Jensen, 2006). Since, in our case, information on the cap-
ital stockof bacterial resistance, is not available, we follow the lagged variable
approach.
The purpose of this article is to explore how consumers adjust their current
level of antibiotic consumption towards desired levels over time. We propose a dy-
namic approach to capture the partial adjustment in consumption and the speed of
the adjustment. We estimate a model of antibiotic consumption using a balanced
panel of outpatient antibiotic use and several socioeconomic determinants in 20
Italian regions between 2000 and 2007. Estimations are carried out by means of
two suitable approaches for short dynamic panels: the bias-corrected least squares
dummy variable (LSDVC) dynamic panel estimator proposed by Kiviet (1995) to
reduce the small sample bias associated to the least squares dummy variables es-
timator, and the generalized method of moments proposed by Blundell and Bond
(1988) (GMM-BB).
Most of our ndings on the impact of determinants of consumption prove
consistent with previous results of static models of antibiotic use. In addition,
we show that past antimicrobial use a¤ects current consumption and that the
adjustment towards desired levels of consumption is relatively fast. This may in-
dicate that individuals are responsive to changes in antibiotic ine¢ cacy (bacterial
resistance).
The remaining of the paper is organized as follows. Section 2 provides an
overview of the three main elds of the literature which are most closely related to
our paper: the empirical analysis of the determinants of antibiotic consumption,
the theoretical literature on optimal antibiotic consumption, and the empirical
literature on addictive goods and habit formation. In Section 3 we sketch the
model and discuss the estimation approach. Section 5 presents the results and
Section 6 concludes.
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2 The dynamics of antibiotic consumption: a review
The literature is relatively rich of studies investigating socioeconomic determi-
nants of antibiotic consumption in outpatients within countries. Nitzan et al.
(2010), for instance, analyse the use of antibiotics in outpatients by di¤erent age
groups in 8 districts of Israel. Filippini et al. (2006) propose an econometric model
where antibiotic use across Swiss regions varies according to the socioeconomic
and demographic characteristics of the population, the incidence of infections, the
local supply of health care and antibiotic price. Kern et al. (2006) investigate
variations in antibiotic prescriptions across 23 areas in 16 German states in re-
lation to age, population density, income, unemployment, and aspects of local
health care supply. Finally, Matuz et al. (2005) explore regional variations in
antibiotic consumption in ambulatory care in Hungary.
The above studies exploit cross-sectional data. To our knowledge, the litera-
ture lacks econometric studies on determinants of outpatient antibiotic consump-
tion using panel data, the only exception being a recent investigation by Masiero
et al. (2010) using a European panel. In a companion paper (González and
Masiero, 2010), we explore variations of antibiotic use across Italian regions using
panel data. The modelling approach is based on ordinary least squares with xed
e¤ects. Spatial econometric tools are also applied to count for the fact that antibi-
otic consumption may be a¤ected by antimicrobial use in neighbouring regions.
However, dynamic aspects of consumption are not considered.
Static models of antibiotic consumption ignore the link between consumers
preferences in di¤erent time periods and assume that an increase in current con-
sumption a¤ects utility in the current period only (Bretteville-Jensen, 2006). Con-
sequently, consumption in di¤erent periods is fully separable, which implies that
individuals are assumed to instantaneously adjust to the optimal level of consump-
tion. However, this may not be very realistic and the reasons will be carefully
discussed in the following section.
The literature on dynamic aspects of consumption can be divided in two main
elds (Chaloupka, 1991). The rst one is represented by studies on endogenous
tastes or habit formation (e.g. Gorman, 1967; Pollak, 1970, 1976; and Boyer,
1983). The second one consists of studies on rational addictive consumption
(Stigler and Becker, 1977; Becker and Murphy, 1988; Becker et al, 1991, 1994).
The main insights of rational addiction are theoretically derived by Becker and
Murphy (1988), who show that addictive behaviour is inuenced by the discount
rate of future consumption, expected income and the price changes. Moreover,
the long-run demand for addictive goods tend to be more elastic than the demand
for non-addictive goods because their consumption at di¤erent moments of time
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are complements. Many empirical studies which follow this seminal work focus on
the comparison between myopic and rational addictive behaviour. Tiezzi (2005),
for instance, investigates the demand for tobacco in Italy using a balanced pseudo-
panel of annual data on tobacco and related products during the period 1972-2000
for the 20 Italian regions and time series data on per capita household tobacco
expenditures during the period 1960-2002 by means of myopic and rational models
of addiction. Similarly, Luo et al. (2003) investigate cigarette consumption in
Japan using time-series data covering from 1960 to 2000.
As for antibiotics, two main aspects inuence their consumption over time.
First, antibiotics have the characteristics of preventive care. In this sense the
use of antibiotics may contribute to reduce the spread of bacterial infections to
other individuals, which may increase future benets from consumption. Second,
current antibiotic use increases the stock of bacterial resistance, which in turn
reduces the e¤ectiveness of antibiotics over time.
The literature generally models bacterial resistance as a negative external-
ity since the risk of transmission of bacterial resistance a¤ects the welfare of the
population (Rudholm, 2002; Elbasha, 2003). This externality depends, at least
partially, upon the quantity of antimicrobials consumed (Coast et al., 1998). An-
tibiotic resistance generates additional costs in the form of increased hospitaliza-
tions, higher mortality rates, and the diversion of resources from other medical
needs into the development of new and more powerful antibiotics (Laxminarayan,
2001). Hence, the full cost of antibiotic treatment includes the monetary cost as
well as the additional cost of reduced e¤ectiveness due to past consumption. These
costs should balance the expected benets from antibiotic treatment at least in
the long run when information is fully available to the consumers. However, the
literature suggests that consumers (and their doctors) are rather myopic when
using antibiotics. Indeed, several factors may contribute to increase antibiotic
consumption, which in turn reduces antibiotic e¤ectiveness over time.
Many theoretical studies address the issue of optimal consumption of antimi-
crobials. Laxminarayan and Weitzman (2002) argue that most patients in region
or country are treated with the same drug for a given infectious disease, which
places high selection pressure on organisms that are susceptible to that particular
drug and increases the likelihood that a resistant strain will evolve and spread.
As resistance to the recommended st-line drug builds up, that drug is replaced
by an alternative that is used until resistance to the second drug also increases,
and so on in succession. The authors concludes that this myopic strategy is not
optimal and should be replaced by the simultaneous prescription of a variety of
drugs.
Rudholm (2002) suggests that the use of antibiotics in one region creates a
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stock of resistant bacteria which a¤ects the welfare of consumers in other regions.
Since consumers do not take this e¤ect into account when choosing the level of
antimicrobial consumption, this may result in a suboptimal allocation of resources
at the global level.
Herrmann and Gaudet (2009) analyse the exploitation of an antibiotic in a
market subject to open access on the part of antibiotic producers to the common
pool of antibiotic e¢ cacy. While the market equilibrium depends only on cur-
rent levels of antibiotic e¢ cacy and infection of the epidemiological system, the
social optimum accounts for the dynamic externalities which relate those levels
to the inter-temporal use being made of the antibiotic. They explicitly derived a
demand function for the antibiotic under the assumption that individuals di¤er
with respect to their valuation of being in good health. Furthermore, the authors
show that in the open-access equilibrium, the level of antibiotic e¢ cacy tends to a
positive steady-state level in which the e¢ cacy renews itself so as to maintain the
steady state. It turns out that this steady-state level of antibiotic e¢ cacy can be
lower or higher than the level which should prevail in the socially optimal steady
state.
Finally, several empirical studies support the idea that there is limited ratio-
nality in antibiotic consumption. Antibiotic prescriptions, for instance, represent
a mean of shortening doctors consultation since there is little time for clinical in-
vestigations to exclude other diagnosis. Moreover, prescribers may be concerned
with the risk of losing patients and the perception of poor outcome if antibiotics
are not prescribed (Sachs and Tomson, 1992; Whyte, 2002). Physicians may also
fear legal consequences if they fail to secure an adequate treatment. Prescribing
may then contribute to relieving doctors anxiety. Uncertainty in the diagnosis
and limitation in the follow up of patients provides an additional concern. This
generates a preference for antibiotics with a broad spectrum to cover the broader
range of bacteria. To conclude, the cost of diagnostic tools makes it di¢ cult to
persuade the patient that antibiotic treatment is not needed (Nordberg et al.,
2005).
3 The model
In this section we sketch a dynamic model of antibiotic consumption in outpatient
care where consumers rationality is limited by poor information available on the
future costs of antibiotic ine¤ectiveness (bacterial resistance). The model builds
on previous approaches to habit formation and addictive goods. Two main aspects
can be considered. First, greater past consumption of antibiotics increases the
desire for present consumption. This represents the so called reinforcement e¤ect
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and indicates that individuals who undergone antibiotic treatment in the past are
more likely to consider the use of antibiotics in the current period.1 Second, the
utility of a given amount of antibiotics (standard doses of therapy) is lower when
past consumption is greater. This is because of endogenous bacterial resistance
which reduces antibiotic e¢ cacy over time. To be cured, a patient will need more
antibiotics since more therapies have to be considered before nding the e¤ective
one to cure the infection.2 Third, there is an optimal stock of bacterial resistance
which depends on individual antibiotic consumption as well as consumption of
other individuals.3
Rational individuals weigh the present benet of antibiotic consumption against
the future health consequences in terms of the risk of antibiotic ine¢ cacy and the
future costs of purchasing new pharmaceutical drugs. However, patients and their
doctors are not fully aware of the future harmful consequences of current antibiotic
consumption. The rationale is that the mechanism that generates antibiotic resis-
tance from past antibiotic consumption is quite complex and the spreading process
to di¤erent antimicrobial categories is not well understood. Doctors have limited
information on levels of antimicrobial resistance and patients may not be able to
evaluate correctly the impact of resistance on future antibiotic e¢ cacy. Moreover,
the future costs of pharmaceutical innovation are not taken into account. Patients
bear a small fraction of the full cost of antibiotics directly because of social health
insurance coverage. Furthermore, the decision to request an antibiotic is based
on two factors: the benet of quickly recovering from an infection and the cost
of taking the medication. Patients, however, may not be aware of studies that
demonstrate conclusively that prior use of antibiotics increases a persons risk of
acquiring a resistance infection (Laxminarayan, 2001). Finally, current antibiotic
ine¢ cacy may also be generated by past antibiotic consumption of other individ-
uals. This implies that the stock of bacterial resistance has an externality e¤ect
1This may be explained by some physical or psychological e¤ects which persist over time.
It may also reect physicians attitude toward antibiotic prescriptions. Under uncertainty on
the nature of patients infection, antibiotic therapy may appear to have been benecial even
though patients relief was not due to the treatment. General practitioners may prefer antibiotic
therapies since they were presumably e¤ective in the past or patients are not willing to wait for
recovery.
2Under uncertainty on antibiotic e¤ectiveness (levels of bacterial resistance), doctors usually
start with the traditional therapy and then move to new antibiotic therapies when the former
proves to be ine¤ective. This implies that the total amount of antibiotic doses will increase.
3From a biological perspective, individuals may experience a level of bacterial resistance which
is positive or zero. This level depends on the individual consumption as well as the consumption
of other individuals. Since the use of antibiotics generates expected benets (infection cured)
and costs (antibiotic ine¢ cacy and monetary costs), individuals should try to optimise their level
of consumption, i.e. to reach the optimal stock of bacterial resistance.
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which is not considered in individuals utility maximizing choices.
We hypothesise that the utility of a representative individual in region i de-
pends on the consumption of a composite good, ci(t), the consumption of antibi-
otics measured by the amount of standard dened daily doses, ai(t), and on a
measure of past consumption which captures the level of ine¢ cacy of antibiotics,
i.e. the stock of bacterial resistance, Ri(t). The latter measure draws from the
classical SIS model used in epidemiological studies (Lindquist et al., 2010). This
denes antibiotic ine¢ cacy as Ri(t) = IRi (t)=Ii(t), where I
R
i (t) represents the
number of individuals infected with a drug-resistant strain and Ii(t) is the total
number of infected individuals in the population. The variation in antibiotic e¢ -
cacy over time, @Ri(t)=@t, is supposed to depend on individuals treated, ni, and
on the tness cost of resistance, . The latter is a measure of the rate at which
bacteria regress to the susceptibility state in the absence of antibiotic treatment.
We can interpret this process as the depreciation rate of the stock of bacterial
resistance. We then assume the following relationship:
@Ri(t)
@t
= 
niX
j=1
aj(t)  Ri(t): (1)
From an economic point of view, the optimal use of antibiotics depends on
whether drugs are a renewable resource. This is related to the depreciation rate
of the stock of bacterial resistance, . If resistant bacteria were less likely to
survive in the absence of antibiotics, one could consider to remove an antibiotic
temporarily from active use to enable it to recover its e¤ectiveness. On the other
hand, if the resistant strain remains prevalent, then an antibiotic would fail to
regain its e¤ectiveness even if it were temporarily removed. E¤ectiveness would
be treated as a non-renewable or exhaustible resource. This would imply higher
costs for pharmaceutical innovation to replace the ine¤ective treatment unless the
exhaustible resource was use more carefully.
Note that antibiotic ine¢ cacy is a function of past consumption of all individu-
als in the region. There is a externality e¤ect represented by the e¢ cacy constraint
generated by antibiotic consumption of other individuals in the region. However,
we hypothesise that bacterial resistance cannot be transferred to individuals in
other regions.4
4Bacterial resistance generated by individual consumption represents an e¢ cacy constraint
for other individuals. It is plausible to assume that bacterial resistance spreads within the region,
i.e. it is a local phenomenon. However, researchers have hypothesized that bacterial resistance
may have global e¤ects (Rudholm, 2002). Spatial aspects have been considered in two previous
papers using cross-sectional data (Filippini et al., 2009a, 2009b), and in a companion paper
(González and Masiero, 2010) using panel data.
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Figure 1: Model of (limited) rational antibiotic consumption. Bacterial resistance,
i.e. the capital stock, reinforces antibiotic consumption since past antibiotic
treatment increases preferences for present treatment and the e¢ cacy from a
given treatment is lower when past consumption is greater (tolerance).
Assuming that individuals in region i are identical, with a length of life equal
to T and a constant rate of time preference, , we can write the utility function:
Ui(0) =
Z T
0
e tui[ci(t); ai(t); Ri(t)]dt, (2)
subject to an expenditure constraint which depends upon the price of antibiotics
and other goods, earnings over time and the discount rate. Individuals maximise
utility in (2) taking the expenditure constraint and the investment equation (1)
into account (see Becker and Murphy, 1988, for details). A stable equilibrium
is depicted in Figure 1 where a and R represent optimal levels of antibiotic
consumption and stock of bacterial resistance.
As shown in Figure 1, the long-run level of antibiotic consumption is fully
adjusted to its equilibrium level. At any point in time, however, current antibiotic
consumption di¤ers from the long-run equilibrium consumption. This may be
imputed to the fact that consumers are not well informed about levels of bacterial
resistance in their area. Nevertheless, bacterial resistance represents a constraint
on antibiotic utilisation. Consequently, a link between antibiotic consumption
in di¤erent periods is plausible. However, while past consumption is supposed
to a¤ect present consumption, it seems plausible to assume that individuals are
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myopic when choosing antibiotic treatment and the possible e¤ects of present
consumption on future consumption are not taken into account.
Due to the fact that we are not able to observe the stock of bacterial resistance
directly, our empirical approach is based on the idea that antibiotic consumption
follows a partial adjustment process where the lagged dependent variable rep-
resents a xed propensity to consumption which is carried over from period to
period. The coe¢ cient of the lagged variable can be interpreted as the speed of
the adjustment to the steady state level of consumption (Tiezzi, 2005). Hence,
current antibiotic use, at, di¤ers from optimal use, a*t, because the adjustment
to optimal levels is not immediate.
In this framework the relationship between current and desired levels of an-
tibiotic consumption can be summarised as:
lnait   lnait 1 = '(lnait   lnait 1) + it, (3)
where t is a random disturbance term and ' is the coe¢ cient of adjustment
indicating the rate of movement towards the desired level of consumption. It is
worth pointing out that for ' = 1 the adjustment to desired levels of antibiotic
consumption is instantaneous. Conversely, for ' = 0 there is no adjustment.
Thus, we hypothesise that 0 < '  1.
Solving (3) for the optimal level of consumption we get:
lnait =
1
'
lnait +

1  1
'

lnait 1   1
'
it. (4)
Since the desired level of consumption ait cannot be observed, equation (4)
reformulates the unobserved at in terms of the observed levels of at and at 1, as
well as the unobserved parameter ' and the random disturbance term it.
To empirically investigate the dynamics of antibiotic use we hypothesise that
regional consumption within a country depends on socioeconomic characteristics
of the population characteristics (income and age structure), the local supply of
health care, the prevalence of community-acquired infections, and antibiotic price
or copayment.
Let the optimal level of antibiotic use in region i at time t, measured in dened
daily doses per 1000 inhabitants, be described by the following reduced form
equation:
lnait = 0 + 1lnYit + 2Pit + 3DPHit + 4POP1it + 5POP2it (5)
+6MORit + 7DPOPit + 8NORTH + 9CENTER+ "it.
In the hybrid log-log functional form of equation (5) Pit is antibiotic price/co-
payment, DPHit is the density of physician practices, POPjit is the percentage
10
of the population in the j age group, MORit is the mortality rate from infec-
tious diseases, and DPOPit is population density. The log transformation is
applied to income only since other variables are dened as percentage ratios and
price/copayment is measured by integers from 0 to 4. Two dummy variables
(NORTH and CENTER) are also included to capture geographical di¤erences
between northern, southern and central regions.
Substituting the right-hand side of equation (5) for lnait in (4) and rearranging
we obtain:
lnait = 0'+ (1  ')lnait 1 + 1'lnYit + 2'Pit + 3'DPHit (6)
+4'POP1it + 5'POP2it + 6'MORit + 7'DPOPit
+8'NORTH + 9'CENTER+ vit.
where (1  ') represents the speed at which individuals achieve the desired level
of consumption and the composite disturbance term is it = '"it+it. The model
derived in (6) can be estimated by means of appropriate econometric techniques
discussed in the following section.
4 Econometric approach and data
For the estimation of the dynamic model in (6) we have a balanced panel dataset
for the 20 Italians regions. To account for unobserved heterogeneity in panel data,
we could use a xed e¤ects (LSDV) or random e¤ects (RE) model. However, the
estimation of the dynamic panel data model (6) using LSDV or RE estimators
is not appropriate. This is because the inclusion of lagged dependent variables
among explanatory variables violates the strict exogeneity assumption. In fact,
the lagged variable is correlated with the error term, which leads to biased and
inconsistent estimates of LSDV and RE.5 In the literature several instrumental
variable estimators have been proposed to solve this problem. Anderson and Hsiao
(1982) proposed a simple instrumental variable estimator. Arellano and Bond
(1991) as well as Blundell and Bond (1998) proposed two di¤erent estimators based
on the general method of moments (GMM). The basic idea of these estimators is
that lagged levels and/or additionally lagged di¤erences are valid instruments for
the lagged endogenous variable, that is they are uncorrelated with the transformed
error term.
The Arellano and Bond estimator (GMM-AB) has the advantage of produc-
ing consistent estimates in dynamic panel regression with both endogenous right-
hand side variables and measurement errors. Moreover, it is more e¢ cient than
5For a discussion of this issue and for a presentation of econometric models for panel data see
Baltagi (2002).
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the standard Instrumental Variables (IV) estimators such as the Anderson-Hsiao
estimator. Nevertheless, the method is unlikely to be suitable for small samples.
It has been shown that, when T is small and the parameter of the lagged variable
is close to one, then the GMM-AB estimator can biased downward. As an alter-
native to the approach suggested by Arellano and Bond (1991), BlundellBond
(1998) proposed a system GMM estimator (GMM-BB) which uses lagged rst
di¤erences as instruments for equations in levels as well as the lagged variable in
rst-di¤erence equations. Blundell-Bond (1998) showed that this estimator seems
to be preferable to other IV and GMM estimators with small samples. A problem
with this estimator is that properties hold for N large, so the estimation results
can be biased in panel data with a small number of cross-sectional units.
An alternative econometric approach for small dynamic panel data set based
on the correction of the bias of LSDV has been suggested by Kiviet (1995). To
make the correction feasible, this procedure has to be initialized by a consis-
tent estimator. This is because the bias approximation depends on the unknown
population parameters. Three possible options to reach this purpose are the
Anderson-Hsiao, the Arellano-Bond, and the Blundell-Bond estimators. Finally,
the estimated asymptotic standard errors may provide poor approximations in
small samples, generating unreliable t-statistics. Bootstrap methods generally
provide approximations to the sampling distributions of statistics, which are at
least as accurate as approximations based upon the rst order asymptotic as-
sumptions.
In a Monte Carlo analysis, Judson and Owen (1999) and Kiviet (1995) showed
that in typical aggregate dynamic panels characterized by T lower or equal to
20 and N lower or equal to 50, as it is our case, the Anderson-Hsiao and the
Kiviet corrected LSDV (LSDVC) estimators are better than the GMM estimator
proposed by Arellano and Bond (1991). Despite having a higher average bias, the
corrected LSDV estimator turns out to be more e¢ cient than the Anderson-Hsiao.
This suggests that the corrected LSDV estimator is an e¤ective approach for small
panels (T  20), while the Anderson-Hsiao estimator is more appropriate for large
panels, as the e¢ ciency of the latter improves with T (Kiviet, 1995).
Our regional panel includes 20 regions for the period 2000   2007. Hence,
the GMM-AB estimator may not be the most appropriate approach. Given the
characteristics of our panel, we choose to estimate the dynamic model (6) using
the following two estimators: the one-step system GMM estimator proposed by
Blundell and Bond (1998) and the LSDVC.6
6Spatial aspects of consumption are not considered here. These aspects are addressed in stud-
ies using cross-sectional data (Filippini et al., 2009a, 2009b) and in a companion paper (González
and Masiero, 2010) using panel data by means of spatial-lag and spatial error econometric ap-
12
The balanced panel dataset for the 20 Italian regions has been created using
several sources. Data on regional outpatient antibiotic consumption were collected
from annual reports prepared by the Italian National Observatory on Drugs Uti-
lization (Osmed). Our dataset includes sales of antimicrobials, i.e. group J of the
Anatomical Therapeutic Chemical Classication (ATC) of drugs. These drugs are
included in class A by the Italian National Health Service (SSN), which means
they require a doctors prescription and are supplied virtually free of charge,
against small patients copayments. The per capita consumption is measured by
the number of dened daily doses per 1000 inhabitants per day (DID). A dened
daily dose represents the standard dose necessary for one day of drug treatment
in adults and is dened by an independent scientic committee answering to the
WHO Collaborating Center for Drug Statistics Methodology. The DID mea-
sure can be interpreted as the number of persons (out of 1000) who are taking
antibiotics on a given day (Chauvin et al., 2001).
The mean level of consumption of outpatient antibiotics in Italy between 2000
and 2007 was 23:24 DID, with a peak in 2006 (23:68) and a minimum in 2000
(22:36). Antimicrobials use has been roughly stable over time but a remarkable
degree of heterogeneity in consumption is observed across the regions. Generally,
regions in central Italy use more antibiotics per capita (24:61 DID) than regions
in the north (18:25 DID) and less than southern regions and the islands (28:36
DID). Summary statistics are reported in Table 1.
Information on the demographic structure of the population and density, per
capita income, density of general practices and mortality from infectious diseases
are obtained from the Italian National Institute of Statistics (Istat). Copayments
are obtained from annual reports on pharmaceutical consumption and expenditure
prepared by Osmed. Regional copayments vary from 0 to 4 Euros. We rescale the
variable from 1 to 5 in order to avoid negative values in the log transformation.
Mortality data for infectious diseases in 2004 and 2005 are not available. Since
data are substantially stable before and after this period, we linearly interpolate
mortality data from 2003 and 2006 to assign values to the years 2004 and 2005.
We are aware that this approximation could create some bias in the estimation.
We then carefully discuss the estimation results related to this covariate in section
5. Finally, it is worth noticing that covariates generally show low within variation.
proaches. In a preliminary stage of this analysis we estimated a spatial dynamic model following
two approaches: the corrected 2SLS approach suggested by Beenstock and Felsenstein (2007)
and the system GMM approach proposed by Kukenova and Monteiro (2009) and Bouayad-Agha
and Védrine (2010). However, the results were not encouraging. This could be due to the fact
that our data set is characterized by a low T and a low N .
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5 Results
In this section, we discuss the results obtained from the estimation of the dynamic
model of antibiotic consumption dened by equation (6). The model is estimated
by means of the GMM-BB and the corrected LSDV estimators. Findings are
summarized in Table 2. The GMM-BB estimates are shown together with the
p-value of the test statistics of serial correlation (AR1, AR2) and over identifying
restrictions (Sargan). The p-values of these statistics show that in both models
there is no signicant second-order autocorrelation, which is the crucial aspect
with respect to the validity of the instruments. Moreover, the p-value of the Sar-
gan test statistics indicates that the null hypothesis that the population moment
conditions are correct cannot be rejected.
In both models, the number of statistically signicant parameter estimates is
relatively low. However, the results are satisfactory as far as the coe¢ cients of
the price variables and the coe¢ cients of the lagged variables are signicant and
carry the expected signs in both models. The reason is that these coe¢ cients
are used for the computation of the long-run elasticities and for the estimation
of the latent impact of antibiotic resistance. The values of these coe¢ cients are
relatively di¤erent between the two models. As expected, the largest di¤erence
concerns the coe¢ cient of the lagged dependent variable. The LSDVC approach
leads to a lower coe¢ cient estimate of the lagged variable. Finally, the signicance
of the lagged variable is also of relevance because it allows for the analysis of the
impact of bacterial resistance on antibiotic consumption.
Generally, the results obtained using the GMM-BB estimator show that so-
cioeconomic and demographic variables such as income and the share of elderly
people, as well as variables reecting the density of doctors and the mortality,
do not seem to have a notable inuence on antibiotic consumption. Only the
coe¢ cient of the population density and two coe¢ cients of the regional dummy
variables are signicant. These dummy variables are plausibly linked to regional
di¤erences in terms of culture, habits and environmental conditions. The results
show that antibiotic consumption is generally lower in central and northern Italian
regions. Furthermore, the positive and signicant coe¢ cient of population density
could be due to the likelihood of infections transmission, which is expected to be
higher in populated regions compared to relatively remote regions.
The results obtained using the LSDVC estimator show that only price, in-
come and health status coe¢ cients are signicant. Regarding the signicance of
the coe¢ cients in general, it is worth noting that several variables have limited
variation within regions over time. The coe¢ cients of the explanatory variables
can be imprecise if variation over time is dominated by variation across states, i.e.
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the between variation (Cameron and Trivedi, 2005). Low within variation may
explain the small number of signicant coe¢ cients.
LSDVC GMM-BB
Obs. 120 Obs. 140
Variables Coe¢ cients St. Err. p-value Coe¢ cients St. Err. p-value
Constant - - - 1.569453 0.959277 0.102
P -0.015516 0.007357 0.035 -0.027835 0.009956 0.005
Y 0.257697 0.084542 0.002 0.046747 0.083528 0.576
POP1 0.007816 0.007191 0.277 -0.002622 0.012070 0.828
POP2 0.000008 0.000082 0.924 -0.000014 0.000102 0.888
DPOP 0.000006 0.000258 0.980 0.000546 0.000155 0.000
DPH 0.154433 0.128217 0.228 -0.016214 0.189424 0.932
MOR -0.026638 0.014860 0.073 -0.000613 0.016870 0.971
NORTH - - - -0.343157 0.100239 0.001
CENTER - - - -0.162410 0.065459 0.013
at 1 0.144826 0.067315 0.031 0.392375 0.088761 0.000
Sargan test - - - - - 0.106
Arellano-Bond - - - - - 0.006
(AR1) test
Arellano-Bond - - - - - 0.968
(AR2) test
Table 2: Parameter estimates of dynamic models of antibiotic consumtion.
Since we use a log-log model specication, we can interpret the coe¢ cients
as elasticities. In the LSDVC, this implies that a 1% increase in the per capita
income increases antibiotic consumption by roughly 0.15% in the short run and
by 0.18% in the long run. This nding indicates that regions with a higher level of
income, i.e. northern regions, use less antibiotics than regions with lower income,
ceteris paribus. Similar results are obtained by Filippini et al. (2009a) using
cross-sectional data from small geographic areas in Switzerland, and by Baye et
al. (1997) using USA data. Hence, the result from our dynamic approach conrms
the evidence of positive income e¤ects.
In accordance with the economic theory, we nd a statistically signicant
and negative association between antibiotic consumption and price/copayment in
both models, even though this impact is relatively low. Using a natural exper-
iment across Italian regions, Fiorio and Siciliani (2009) investigate the e¤ect of
copayments on drug prescriptions. They nd that an increase in the copayment
by one Euro reduces the per capita number of prescriptions by 4% and the per
capita public pharmaceutical expenditures by 3.4%.
The dynamics of antibiotic use is captured by the coe¢ cient of the lagged
variable of consumption, at 1. In both models, this coe¢ cient is positive, statisti-
cally signicant but relatively low (0:145 and 0:392). This suggests that the time
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of adjustment time is also relatively low. In fact, the gap between current and
desired antibiotic consumption is almost fully o¤set within one year. The full ad-
justment occurs in approximately 1:17 years if we consider the estimation results
of the LSDVC model, and 1:64 years using the GMM-BB estimation results. In
other words, antibiotic consumption seems to move towards optimal levels quite
fast. We can conclude that persistence in consumption appears to be relatively
weak, which suggests that individuals set their level of antimicrobial use over time
close to the optimal level.
6 Conclusions
Antibiotic misuse increases the threat of bacterial resistance which in turn reduces
antibiotic e¤ectiveness over time (Elbasha, 2003). The understanding of factors
inuencing the dynamics of antibiotic consumption may then contribute to the
shaping of appropriate measures of public interventions to optimise the use of
antimicrobials. The empirical literature is lacking in this respect.
In this paper, we propose a dynamic approach to investigate antibiotic use
in outpatient care which hypothesises that antibiotic consumption is a¤ected by
antibiotic ine¢ cacy, i.e. the stock of bacterial resistance to antimicrobials. The
level of ine¢ cacy represents a bad which is indirectly measurable by means of
past antibiotic use. This represents the main novelty of our analysis and pro-
vides a signicant contribution to the existing empirical literature on antibiotic
consumption.
To some extent, antibiotics exhibit aspects which make them similar to addic-
tive goods, such as cigarettes. Past antibiotic use decreases the marginal benet
from consumption over time, which implies that higher levels of consumption are
required to maintain the same level of treatment e¢ cacy to cure bacterial infec-
tions. Thus, consumers adjust their current levels of consumption towards optimal
levels depending on the expected benet from antibiotic treatment and the cost
of bacterial resistance.
We show that individuals adjust their levels of consumption in a relatively
short period. Hence, outpatient antibiotic consumption exhibits a low degree of
persistence. The rationale may be that bacterial resistance represents a constraint
which can hardly be ignored by consumers unless to incur in dangerous threats
to their health.
Our ndings may also suggest that public policies to preserve antibiotic ef-
cacy could be improved. E¤orts to restrict antibiotic use in outpatients have
been much less successful than in hospitals because no central agent (such as a
hospital administrator or infection control committee) can enforce an antibiotic
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policy (Harbarth and Samore, 2005). Moreover, the high costs of malpractice
lawsuits may induce doctors to use stronger and broader spectrum antibiotics
more frequently than it would be necessary. This behaviour increases the level
of resistance in the community, but the impact of each individual treatment is so
small that doctors perceived benet from antibiotic prescriptions often outweighs
the small uncertain costs associated with increased resistance (Brown and Layton,
1996). Finally, it has been asserted that policies on patent protection for antimi-
crobial drugs may not be optimal. Allowing for longer patent life could increase
incentives for pharmaceutical rms to minimise resistance, since companies would
enjoy a longer period of monopoly benets from their antibiotic e¤ectiveness (Her-
rmann, 2010). Further research is desirable to assess the impact of public policies
in preserving antibiotic e¤ectiveness.
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